Ophthonix Presents at JP Morgan Healthcare Conference

January 12, 2006

Ophthonix Presents at JP Morgan Health Conference
JPMorgan Annual Healthcare Conference 2006 
SAN DIEGO--(BUSINESS WIRE)--Jan. 12, 2006--Ophthonix, a company producing "high definition" vision technology that provides consumers with superior optical clarity and crispness compared to any other available vision correction, announced it has presented at the JP Morgan 24th Annual Conference held Jan. 9-12 in San Francisco.

Andreas Dreher, Ph.D., president and CEO of Ophthonix, discussed the company's proposition, strategies and direction, including the recent successful launch of the customized iZon™ Wavefront-Guided Eyeglasses. Dr. Dreher also provided information about a recent study on nighttime driving, which showed vision and reaction while driving at night are significantly improved with the iZon eyeglasses over conventional lenses. The study, conducted in a controlled FDA-recognized night-driving simulator demonstrated that with iZon eyeglasses a driver can identify and react to a pedestrian 25 feet sooner at 55 mph. For perspective, this is greater than two car lengths or the distance across a typical intersection.

About Ophthonix

Ophthonix Inc., a San Diego-based, venture-funded ophthalmic company, is developing exceptional vision assessment and correction technologies to greatly enhance visual acuity. Ophthonix is currently advancing a system that will improve the ability of optometrists and ophthalmologists to care for their patients and benefit the millions around the world requiring vision correction. Ophthonix is located at 10455 Pacific Center Court, San Diego, CA 92121, www.ophthonix.com, media@ophthonix.com, 858-869-2086.

Ophthonix is a venture-funded company supported by these premier firms:

          Enterprise Partners Venture Capital
Gund Investment Corp.
Kleiner Perkins Caufield & Byers
Trex Enterprises Corp.
InterWest Partners
Wasatch Advisors

View the archives